TVB-3567

· Sagimet Biosciences Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TVB-3567, covering 2026-02-06 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne [Phase 1]

See pricing